
John A. Morren, MD, FAAN
@jamorren
Neuromuscular Neurologist, Cleveland Clinic
Program Director, Neuromuscular Medicine Cleveland Clinic
#thoughts=mine
ID: 449343762
29-12-2011 01:07:19
28 Tweet
57 Followers
81 Following


In this paper, we looked at the predictors of disability and mortality in CRMP5-IgG paraneoplastic neurologic disorders. SCLC was the main determinant of mortality. Amy Kunchok Justin Abbatemarco John A. Morren, MD, FAAN Check out our recent publication: onlinelibrary.wiley.com/doi/full/10.10… Cleveland Clinic Neurology Residents


📣 Finally in print! Check out our review with John A. Morren, MD, FAAN about the novel MG therapeutics: doi.org/10.1080/146565… Complement and FcRn inhibitors, B cell depletors, CAR-T cell therapy offer potentially better efficacy and safety compared to the conventional MG treatment options.

Honored giving the Reiner Plenary- "AI & the Future of EDX & NM Medicine" & the "Harnessing the Power of AI: Exploring AI Tools" sessions anam hussain Annual Meeting. Awesome engagement & AI interest conveyed throughout the meeting!👋 #AANEM #aaneminsavannah #NeuromuscularMedicine #EDX




November is National Family Caregivers Month! We’re celebrating the dedication of those who help loved ones w/ neuromuscular diseases - managing appointments & providing comfort & tackling daily hurdles, caregivers are true heroes, making an impact every day! American Neuromuscular Foundation






